guest :: login
DKFZ
    Search   Submit  
Personalize
  • Your alerts
  • Your baskets
  • Your searches
  Help    
Home > Publications database > Efficacy, safety and differential outcomes of immune-chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: A multicenter real world cohort. > Access to Fulltext
  • Information
  • Files
 
 
Efficacy, safety and differential outcomes of immune-chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: A multicenter real world cohort. - DKFZ-2024-01905
 
Main document file(s):
      UEG Journal - 2024 - Mitzlaff - Efficacy safety and differential outcomes of immune‐chemotherapy with gemcitabine
    version 1
    UEG Journal - 2024 - Mitzlaff - Efficacy safety and differential outcomes of immune‐chemotherapy with gemcitabine .pdf [633.14 KB] 23 May 2025, 12:13
    UEG Journal - 2024 - Mitzlaff - Efficacy safety and differential outcomes of immune‐chemotherapy with gemcitabine .pdf (pdfa) [512.63 KB] 23 May 2025, 12:13
Similar records

DKFZ :: Search :: Submit :: Personalize :: Help
Powered by Invenio 1.1.7-dirty
Maintained by zb.invenio@dkfz-heidelberg.de

Impressum | Data Privacy Policy